SHENG-KAI LIANGChien, Li-HsinLi-HsinChienChang, Gee-ChenGee-ChenChangTsai, Ying-HuangYing-HuangTsaiSu, Wu-ChouWu-ChouSuChen, Yuh-MinYuh-MinChenHuang, Ming-ShyanMing-ShyanHuangLin, Hsien-ChihHsien-ChihLinFang, Wen-TsenWen-TsenFangHung, Hsiao-HanHsiao-HanHungJiang, Shih-ShengShih-ShengJiangChen, Chih-YiChih-YiChenKUAN-YU CHENChang, I-ShouI-ShouChangHsiung, Chao AChao AHsiungChen, Chien-JenChien-JenChenPAN-CHYR YANG2022-04-282022-04-2820212234-943Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/608170Lung cancer in never-smokers is a distinct disease associated with a different genomic landscape, pathogenesis, risk factors, and immune checkpoint inhibitor responses compared to those observed in smokers. This study aimed to identify novel single nucleotide polymorphisms (SNPs) of programmed death-1 (encoded by PDCD1) and its ligands, programmed death ligand 1 (CD274) and 2 (PDCD1LG2), associated with lung cancer risk in never-smoking women.encarcinogenesis; lung adenocarcinoma; programmed death ligand-2; pulmonary tuberculosis; single nucleotide polymorphism[SDGs]SDG3Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokersjournal article10.3389/fonc.2021.753788346315912-s2.0-85116943233WOS:000705925100001https://scholars.lib.ntu.edu.tw/handle/123456789/585318